Atopic dermatitis (AD) is a chronic skin disease associated with intense itch and reduced quality of life.

This analysis demonstrated the association among itch severity, poor sleep, and reduced work productivity in patients with moderate-to-severe AD. Treatment with abrocitinib was shown to reduce itch, which in turn improved sleep outcomes, resulting in less work impairment.